
Uncover the Next Big AI Opportunity: Why Investors Are Buzzing About Tempus AI
Tempus AI, Inc. is leading the way in cancer diagnostics using advanced technology. The company possesses a valuable database of 200 petabytes that combines clinical and genomic data. Projected revenues for Q4 are around $200 million, with annual expectations nearing $693 million.